Premium
Greenwich LifeSciences Inc (GLSI)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.02 | -0.161290322581 | 12.4 | 13 | 11.58 | 24468 | 12.15860771 | CS |
| 4 | -0.33 | -2.59638080252 | 12.71 | 14.41 | 11.58 | 28538 | 12.72589475 | CS |
| 12 | -0.5803 | -4.4775198105 | 12.9603 | 15.47 | 10.52 | 33639 | 12.86483795 | CS |
| 26 | -1.31 | -9.56902848795 | 13.69 | 16.5 | 10.52 | 31373 | 13.47143558 | CS |
| 52 | 3.44 | 38.4787472036 | 8.94 | 21.44 | 8.7 | 40372 | 14.56105424 | CS |
| 156 | -8.62 | -41.0476190476 | 21 | 24.46 | 6.8241 | 60791 | 12.25426193 | CS |
| 260 | 7.38 | 147.6 | 5 | 158.07 | 3.262 | 139875 | 35.9234738 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
